FDA halts Juno’s gene-altering cancer trials after three deaths

By David Lumb From engadget Company stock plummeted 27 percent after the suspension. The Food and Drug Administration has temporarily halted a cancer-treating study after three patients died of swelling in the brain. Biopharmaceutical company Juno Therapeutics had been testing an…